SORLA protein reduces tau tangles and brain shrinkage in Alzheimer's mouse models

Researchers have found that boosting the SORLA protein sharply reduced toxic tau aggregates and synaptic loss in mice, identifying a potential new target for Alzheimer's disease research.

Published · AI-drafted summary based on 1 public source
Illustration for generic story
Illustrative image — not from the source article.
Share

A study reported by ScienceDaily on 18 November 2026 describes how researchers investigated the role of the protein SORLA (also known as SORL1) in Alzheimer's disease pathology. Working in mouse models, the team found that experimentally increasing SORLA levels significantly reduced accumulation of toxic tau tangles, protected synaptic connections between neurones, and attenuated the brain-volume loss associated with neurodegeneration. Conversely, removing SORLA from the animals worsened all three outcomes, suggesting the protein plays a constitutive protective role rather than merely a compensatory one.

SORLA is encoded by the SORL1 gene, which has previously been identified through genome-wide association studies as a risk locus for late-onset Alzheimer's disease. This new functional work adds mechanistic detail to that genetic signal, linking SORLA activity directly to tau pathology as well as to previously described roles in amyloid precursor protein trafficking.

The findings are at a preclinical stage; no primary journal citation or institutional affiliation was included in the feed item, and the full paper could not be verified from the available lede alone. The work is nonetheless of interest to researchers studying neurodegenerative disease mechanisms and the translational genetics of Alzheimer's risk variants.

Plain-language version

For patients, families, and general readers. Educational only — not medical advice.

Scientists studying Alzheimer's disease have found that a protein called SORLA — made by a gene already known to affect Alzheimer's risk — appears to protect brain cells in mice. When researchers increased the amount of SORLA in mice, there were fewer of the sticky protein clumps called tau tangles, the connections between brain cells were better preserved, and there was less brain shrinkage. When they removed SORLA, the damage got worse. This research was done in animals, so it is a long way from becoming a treatment for people. Researchers now need to understand how SORLA works in detail before any potential therapy could be developed and tested in humans. This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.

Sources

Read the original reporting — these are the public sources this summary draws from.

  1. Primary source ScienceDaily · 2026-11-18
    A little-known protein could be a powerful weapon against Alzheimer's

Tags

sorla sorl1 alzheimers-disease tau neurodegeneration mouse-models neuroscience
Share

About Genetic Current

Educational summaries of public genetics news

Genetic Current is the news section of Evagene, an academic, research, and educational pedigree-modelling platform. Stories are AI-drafted summaries of items from trusted public sources, written for researchers, clinicians, educators, students, genealogists, and patients with an interest in genetics. Summaries are for educational and research purposes only and are not medical advice.

Join the Evagene Alpha Waiting List